Medical devices, healthcare technology and the business of care
PMA approval · P120016

VASCADE VASCULAR CLOSURE SYSTEM

Cardiva Medical, Inc. · Decision date Jan 31, 2013

MEDTECHLEDGER EXPLANATIONP120016

What did the FDA approve?

FDA approved the VASCADE Vascular Closure System under PMA P120016 on January 31, 2013. The approval covers femoral arterial access site closure while reducing times to hemostasis and ambulation in patients who have undergone diagnostic or interventional endovascular procedures using a 5F, 6F, or 7F procedural sheath.

The approval also covers reducing time to discharge eligibility, but only for patients who have undergone diagnostic endovascular procedures using a 5F, 6F, or 7F procedural sheath. The statement does not include safety or effectiveness data, and the source fields do not identify any supplement or change to a prior PMA.

FDA approval order statement

APPROVAL FOR THE VASCADE¿ VASCULAR CLOSURE SYSTEM (VCS). THIS DEVICE IS INDICATED FOR FEMORAL ARTERIAL ACCESS SITE CLOSURE WHILE REDUCING TIMES TO HEMOSTASIS AND AMBULATION IN PATIENTS WHO HAVEUNDERGONE DIAGNOSTIC OR INTERVENTIONAL ENDOVASCULAR PROCEDURES USING A 5F, 6F, OR 7F PROCEDURAL SHEATH. THE VASCADE VCS IS ALSO INDICATED TO REDUCE TIME TO DISCHARGE ELIGIBILITY IN PATIENTS WHO HAVE UNDERGONE DIAGNOSTIC ENDOVASCULAR PROCEDURES USING A 5F, 6F, OR 7F PROCEDURAL SHEATH.
Regulatory pathway
Original PMA
Clinical specialty
Cardiovascular
Decision date
Jan 31, 2013

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P120016
Regulatory pathway
Premarket approval application
Product code
MGB
Decision code
APPR
Decision date
Jan 31, 2013
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Device, hemostasis, vascular.

Product code
MGB
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P120016 received

    Application receipt date recorded by FDA.

  2. P120016 · FDA decision

    APPR

  3. P120016/S043 · Related supplement

    VASCADE 5F Vascular Closure System

Timeline entries are records held by MedtechLedger for P120016. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P120016

Product / regulatory recordCompanyPathwayDecision dateSource
Cardiva Medical, Inc.PMA supplementSep 10, 2026FDA

Explore the linked device profile

Other records with product code MGB

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Cardiva Medical, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
2900 Lakeside Dr., Suite 160, Santa Clara, CA, 95054

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records